Skip to main content
. 2022 Jan 17;54(4):1209–1218. doi: 10.4143/crt.2021.963

Table 2.

Germline mutant patient characteristics

Patient ID Age (yr) Stage Histology Gene AA change Variant type
CC_006 35 IIA ADC MPL W398X Nonsense variant
CC_007 44 IIA SCC MMP1 A330LfsX45 Frame shift variant
CC_015 41 IB SCC PMS1 K894RfsX17 Frame shift variant
CC_019 36 IB SCC AXIN2 R714W Missense variant
CC_028 60 IB SCC BRCA1 c.4358-2A>G Splice variant
CC_028 60 IB SCC BRIP1 S618* Nonsense variant
CC_034 66 IB SCC EPCAM L78R Missense variant
CC_036 59 IIA SCC PALB2 S537L Missense variant
CC_039 50 IB SCC MUTYH Y453C Missense variant
CC_039 50 IB SCC TP53 A86V Missense variant
CC_056 43 IIA SCC BRCA2 S2414* Nonsense variant
CC_072 38 IB ADC FANCE S157Kfs*21 Frame shift variant
CC_079 41 IIA SCC BRCA1 S451Lfs*20 Frame shift variant
CC_081 44 IB ADC MLH1 S295G Missense variant
CC_111 42 IB SCC FANCM L923Cfs*3 Frame shift variant

ADC, adenocarcinoma; SCC, squamous cell carcinoma.